跳至主要内容
临床试验/ACTRN12620000778987
ACTRN12620000778987尚未招募未知

Persistent lung and arterial inflammation following COVID-19 pneumonia

Sir Charles Gairdner Hospital0 个研究点目标入组 30 人开始时间: 2020年7月30日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • · Both males and females aged 50 years or greater.
  • · At minimum of 30 days and no more than 45 days post COVID-19 pneumonia diagnosis.
  • · Recovered as defined by nasal or oropharyngeal swab confirmed as negative for SARSCoV-
  • 2 in the recovery phase of their illness.
  • · Evidence of pulmonary infiltrates on chest x-ray or Chest CT (multilobar, interstitial or
  • ground glass opacities) suggestive of pneumonia during index admission.
  • · Able to provide informed consent and undergo study procedures

排除标准

  • · Clinically unstable patients considered unsuitable for 18FDG-PET/CT test
  • · COVID-19 status unknown at the time of enrolment.
  • · People with poorly controlled diabetes
  • · People with known immuno-deficiency or active malignancy.

研究者

相似试验